Last reviewed 2026-05-14 · How we verify

HLX60 combined with HLX10

Shanghai Henlius Biotech · Phase 1 active Biologic

HLX60 combined with HLX10 is a Biologic drug developed by Shanghai Henlius Biotech. It is currently in Phase 1 development.

At a glance

Generic name	HLX60 combined with HLX10
Sponsor	Shanghai Henlius Biotech
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HLX60 combined with HLX10 CI brief — competitive landscape report
HLX60 combined with HLX10 updates RSS · CI watch RSS
Shanghai Henlius Biotech portfolio CI

Frequently asked questions about HLX60 combined with HLX10

What is HLX60 combined with HLX10?

HLX60 combined with HLX10 is a Biologic drug developed by Shanghai Henlius Biotech.

Who makes HLX60 combined with HLX10?

HLX60 combined with HLX10 is developed by Shanghai Henlius Biotech (see full Shanghai Henlius Biotech pipeline at /company/shanghai-henlius-biotech).

What development phase is HLX60 combined with HLX10 in?

HLX60 combined with HLX10 is in Phase 1.

Manufacturer: Shanghai Henlius Biotech — full pipeline
Compare: HLX60 combined with HLX10 vs similar drugs
Pricing: HLX60 combined with HLX10 cost, discount & access